Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

por Goure, William F, Krafft, Grant A, Jerecic, Jasna, Hefti, Franz
Publicado 2014

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

por Krafft, Grant A., Jerecic, Jasna, Siemers, Eric, Cline, Erika N.
Publicado 2022

A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid

por Yang, Ting, O’Malley, Tiernan T, Kanmert, Daniel, Jerecic, Jasna, Zieske, Lynn R, Zetterberg, Henrik, Hyman, Bradley T, Walsh, Dominic M, Selkoe, Dennis J
Publicado 2015

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

por Wang, Xueying, Kastanenka, Ksenia V., Arbel-Ornath, Michal, Commins, Caitlin, Kuzuya, Akira, Lariviere, Amanda J., Krafft, Grant A., Hefti, Franz, Jerecic, Jasna, Bacskai, Brian J.
Publicado 2018